Daming Shan - Concepedia

Concepedia

Author

Daming Shan

Fred Hutch Cancer Center

Also Known As

D Shan, Da-Ming Shan, Daming Shan

12

Publications

1.2K

Citations

9

H-Index

30

Concepts

All Affiliations

Fred Hutch Cancer Center First Affiliated Hospital of Wenzhou Medical University Wenzhou Medical University Bristol-Myers Squibb (United States)University of Washington Medical Center

DS

About

Daming Shan is an author at Fred Hutch Cancer Center specializing in immunology, immunotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Cell Biology	6	6	1K
3	Natural Sciences	1	1	64
4	Biomolecular Engineering	1	1	64
5	Cellular Therapies	1	1	13

Daming Shan

×

9

Publications

1.2K

Citations

9

H-Index

	Year	Citations
Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press Blood ApoptosisImmunologyImmune RegulationCell DeathImmunodominance	1998	571
Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press Cancer Immunology Immunotherapy Anti-cd20-induced ApoptosisMalignant Blood DisorderApoptosisImmunologyCell Death	2000	381
Characterization of scFv-Ig Constructs Generated from the Anti-CD20 mAb 1F5 Using Linker Peptides of Varying Lengths Daming Shan, Oliver W. Press, Theta T. Tsu, The Journal of Immunology Scfv-ig ConstructsUsing Linker PeptidesMedicineNatural SciencesPeptide Library	1999	64
The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2 in vitro and in Immune Competent Mice Panyuan Li, Lingcong Yang, Tong Li, Frontiers in Oncology	2020	52
Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press Blood	1998	45
Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells. Daming Shan, Ajay K. Gopal, Oliver W. Press PubMed Retinoic Acid DerivativesChemoprevention StrategyApoptosis InductionMalignant Blood DisorderApoptosis	2001	26
Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3ζ recombinant gene Kang Yu, Yongxian Hu, Yinxia Tan, Leukemia & lymphoma/Leukemia and lymphoma T-regulatory CellImmunologyImmunologic MechanismImmune Cell TherapyT Cells	2008	19
Adoptive Antitumor Immunotherapy In Vitro and In Vivo Using Genetically Activated erbB2-specific T Cells Chaoyan Wang, Wangxiong Hu, Luxi Shen, Journal of Immunotherapy Cell TherapyImmunologyImmunoeditingImmunotherapeuticsImmune Cell Therapy	2014	13
Gene Therapy of Malignant Solid Tumors by Targeting erbB2 Receptors and by Activating T Cells Wangxiong Hu, Heping Chen, Kang Yu, Cancer Biotherapy and Radiopharmaceuticals Erbb2 ReceptorsImmunologyImmunoeditingImmunodominanceAnti-erbb2 Mab	2012	11

Page 1